451 related articles for article (PubMed ID: 14518695)
1. Advances in the development of ribozymes and antisense oligodeoxynucleotides as antiviral agents for human papillomaviruses.
Alvarez-Salas LM; Benítez-Hess ML; DiPaolo JA
Antivir Ther; 2003 Aug; 8(4):265-78. PubMed ID: 14518695
[TBL] [Abstract][Full Text] [Related]
2. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus-mediated transfer of human papillomavirus 16 E6/E7 antisense RNA and induction of apoptosis in cervical cancer.
Hamada K; Shirakawa T; Gotoh A; Roth JA; Follen M
Gynecol Oncol; 2006 Dec; 103(3):820-30. PubMed ID: 16908054
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus-mediated transfer of HPV 16 E6/E7 antisense RNA to human cervical cancer cells.
Hamada K; Sakaue M; Alemany R; Zhang WW; Horio Y; Roth JA; Mitchell MF
Gynecol Oncol; 1996 Nov; 63(2):219-27. PubMed ID: 8910631
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins.
Yugawa T; Kiyono T
Rev Med Virol; 2009 Mar; 19(2):97-113. PubMed ID: 19156753
[TBL] [Abstract][Full Text] [Related]
6. Ribozyme-mediated in vitro cleavage of transcripts arising from the major transforming genes of human papillomavirus type 16.
Lu D; Chatterjee S; Brar D; Wong KK
Cancer Gene Ther; 1994 Dec; 1(4):267-77. PubMed ID: 7627817
[TBL] [Abstract][Full Text] [Related]
7. Cellular and molecular alterations in human epithelial cells transformed by recombinant human papillomavirus DNA.
DiPaolo JA; Popescu NC; Alvarez L; Woodworth CD
Crit Rev Oncog; 1993; 4(4):337-60. PubMed ID: 8394744
[TBL] [Abstract][Full Text] [Related]
8. High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients.
de Boer MA; Jordanova ES; Kenter GG; Peters AA; Corver WE; Trimbos JB; Fleuren GJ
Clin Cancer Res; 2007 Jan; 13(1):132-8. PubMed ID: 17200347
[TBL] [Abstract][Full Text] [Related]
9. Preclinical study on gene therapy of cervical carcinoma using adeno-associated virus vectors.
Kunke D; Grimm D; Denger S; Kreuzer J; Delius H; Komitowski D; Kleinschmidt JA
Cancer Gene Ther; 2000 May; 7(5):766-77. PubMed ID: 10830724
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo inhibition of human papillomavirus type 16 E6 and E7 genes.
Tan TM; Ting RC
Cancer Res; 1995 Oct; 55(20):4599-605. PubMed ID: 7553636
[TBL] [Abstract][Full Text] [Related]
11. Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP-1 translocation, and modulation of apoptosis.
Divya CS; Pillai MR
Mol Carcinog; 2006 May; 45(5):320-32. PubMed ID: 16526022
[TBL] [Abstract][Full Text] [Related]
12. The prevalence of HPV-18 and variants of E6 gene isolated from cervical cancer patients in Taiwan.
Chang CH; Chen TH; Hsu RC; Chou PH; Yang JJ; Hwang GY
J Clin Virol; 2005 Jan; 32(1):33-7. PubMed ID: 15572004
[TBL] [Abstract][Full Text] [Related]
13. Growth inhibition of human papillomavirus 16 DNA-positive mouse tumor by antisense RNA transcribed from U6 promoter.
He Y; Huang L
Cancer Res; 1997 Sep; 57(18):3993-9. PubMed ID: 9307284
[TBL] [Abstract][Full Text] [Related]
14. RNA interference against human papillomavirus oncogenes in cervical cancer cells results in increased sensitivity to cisplatin.
Putral LN; Bywater MJ; Gu W; Saunders NA; Gabrielli BG; Leggatt GR; McMillan NA
Mol Pharmacol; 2005 Nov; 68(5):1311-9. PubMed ID: 16120770
[TBL] [Abstract][Full Text] [Related]
15. Reversal of the malignant phenotype of cervical cancer CaSki cells through adeno-associated virus-mediated delivery of HPV16 E7 antisense RNA.
Wu S; Meng L; Wang S; Wang W; Xi L; Tian X; Chen G; Wu Y; Zhou J; Xu G; Lu Y; Ma D
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2032-7. PubMed ID: 16609012
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of three ribozymes for cleavage of an RNA transcript from human papillomavirus type 18.
Chen Z; Kamath P; Zhang S; Weil MM; Shillitoe EJ
Cancer Gene Ther; 1995 Dec; 2(4):263-71. PubMed ID: 8548580
[TBL] [Abstract][Full Text] [Related]
17. Genetic diversity of human papillomavirus type 16 E6, E7, and L1 genes in Italian women with different grades of cervical lesions.
Cento V; Ciccozzi M; Ronga L; Perno CF; Ciotti M
J Med Virol; 2009 Sep; 81(9):1627-34. PubMed ID: 19626616
[TBL] [Abstract][Full Text] [Related]
18. HPV and cervical cancer: updates on an established relationship.
Subramanya D; Grivas PD
Postgrad Med; 2008 Nov; 120(4):7-13. PubMed ID: 19020360
[TBL] [Abstract][Full Text] [Related]
19. Identification of a proliferation gene cluster associated with HPV E6/E7 expression level and viral DNA load in invasive cervical carcinoma.
Rosty C; Sheffer M; Tsafrir D; Stransky N; Tsafrir I; Peter M; de Crémoux P; de La Rochefordière A; Salmon R; Dorval T; Thiery JP; Couturier J; Radvanyi F; Domany E; Sastre-Garau X
Oncogene; 2005 Oct; 24(47):7094-104. PubMed ID: 16007141
[TBL] [Abstract][Full Text] [Related]
20. HPV induced cervical carcinogenesis: molecular basis and vaccine development.
Kaufmann AM; Backsch C; Schneider A; Dürst M
Zentralbl Gynakol; 2002 Nov; 124(11):511-24. PubMed ID: 12796844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]